KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients

By C. Hartinger, M. Jakupec, Stefanie Zorbas-Seifried, M. Groessl, Alexander E Egger, W. Berger, H. Zorbas, P. Dyson, B. Keppler. Chemistry and Biodiversity, 2008

689 citations recorded by the source corpus.

Subfields: Inorganic Chemistry, Materials Chemistry, Oncology

View Paper: https://www.semanticscholar.org/paper/67eae35d1f478667082e0d8eb5b23dee0066a0dd